Effects of certain indoleamines in the hippocampal-septal circuit.
D006916:5-Hydroxytryptophan / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D002027:Bufotenin / Q000494:pharmacology; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D003401:Creatine / Q000494:pharmacology; D004594:Electrophysiology; D006624:Hippocampus / Q000187:drug effects*; D007478:Iontophoresis; D008564:Membrane Potentials / Q000187:drug effects; D004130:N,N-Dimethyltryptamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010070:Oxalates / Q000494:pharmacology; D012686:Septal Nuclei / Q000187:drug effects*; D012688:Septum Pellucidum / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013431:Sulfates / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology*; D014364:Tryptophan / Q000494:pharmacology
D010070:Oxalates; D013431:Sulfates; D014363:Tryptamines; D002027:Bufotenin; D012701:Serotonin; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D003401:Creatine; D002746:Chlorpromazine; D004130:N,N-Dimethyltryptamine; D009638:Norepinephrine